Alerts will be sent to your verified email
Verify EmailBMLL
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Bio Medica Laboratories Ltd. manufactures pharmaceutical parenteral formulations, including liquid and dry powder injectables for human and veterinary use. The company operates GMP-compliant facilities and offers contract manufacturing services.
Bio Medica Laborator major competitors are Zenotech Laboratorie, Shukra Pharma.
Market Cap of Bio Medica Laborator is ₹0 Crs.
While the median market cap of its peers are ₹736 Crs.
Bio Medica Laborator seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Claude
|
